Home › Therapeutic areas › Metabolic › Congenital Adrenal Hyperplasia
Congenital Adrenal Hyperplasia (2 companies)
Companies with an active program in Congenital Adrenal Hyperplasia.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals | MetabolicOncology Rare | 1 | Approved | — | 6 |
| SPRB | Spruce Biosciences | Metabolic Rare | 1 | Preclinical | $134M | 2 |
No companies match.